AmeriFlex Group’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-10
Closed -$783 – 1437
2026
Q2
$783 Buy
+10
New +$682 ﹤0.01% 1453
2025
Q2
– Sell
-500
Closed -$31.9K – 1152
2025
Q1
$31.9K Hold
500
– – 0.01% 589
2024
Q4
$28.3K Buy
+500
New +$25.6K 0.01% 558

Other funds holding HALO

AmeriFlex Group's HALO Position: Q3 2026 in Review

AmeriFlex Group sold out of Halozyme (HALO) in Q3 2026, closing a stake of 10 shares — an estimated $783 sold.

AmeriFlex Group first reported a position in HALO in Q4 2024 and held it in 3 quarters. The position peaked at $31.9K in Q1 2025. 734 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • AmeriFlex Group reported no remaining Halozyme position as of Q3 2026 after selling out during the quarter.
  • AmeriFlex Group sold 10 Halozyme shares in Q3 2026, an estimated $783.
  • AmeriFlex Group first reported a position in Halozyme in Q4 2024 and held it in 3 quarters.
  • AmeriFlex Group's Halozyme position peaked at $31.9K in Q1 2025.
  • 734 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on AmeriFlex Group's 13F filing for Q3 2026, filed 13 Nov 2026.